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Quality of Recovery after anesthesia 
 
 
Background: The Quality of Recovery 40 (Qor-40) has been shown to measure health 
status after surgery. The aim of our study was to evaluate the incidence of Poor Quality 
of Recovery (PQR) in the PACU (Post Anesthesia Care Unit) and to compare their QoR 
scores before surgery, 24 hours after surgery and 3 months later. 
Methods: Observational prospective study approved by the institutional ethics 
committee, written informed consent was obtained. Adult Portuguese-speaking 
patients submitted to elective non-cardiac and non-neurological surgery were eligible 
to the study. Demographics data and perioperative variables were recorded. The 
validated Portuguese version of the QoR-40 was used to measure health status before 
surgery (T0), 24h after anesthesia (T1) and 3 months after surgery (T2). PQR was 
defined for patients with QoR-40 score lower to the mean QoR40 score at T1 minus 1 
standard deviation. Descriptive analyses were used to summarize data. Non-
parametric tests were performed for comparisons. 
Results: Mean QoR-40 score was 169 and PQR patients were identified if their QoR-40 
score was lesser than 142. PQR occurred in 26 patients (24%). Global median scores for 
PQR patients were lower at T0 (121 vs. 184, p<0.001), at T1 (120 vs. 177, p<0.001) and 
at T2 (119 vs. 189, p<0.001). At T1 PQR patients showed lower median scores for 
emotional state, physical comfort and pain. 
Discussion: Patients with PQR measured 24 hours after surgery have lower QoR scores 
prior to surgery, which suggests that these patients might be identified before surgery 
using QoR-40. Patients with PQR 24 hours after surgery have lower QoR-40 scores 3 
months later, which indicates lower quality of life. This may allow earlier and more 
effective interventions in order to improve recovery of patients undergoing surgery. 
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Introduction 
Post-operative recovery is a key outcome in the perspective of anesthesiologists. It is 
defined as the patients return to the normal state after a surgery, and has traditionally 
been referred in terms of pain scores, duration of hospital stay, and return to normal 
activities [1]. It involves several factors such as regain of physical, physiologic and 
social functions. It is therefore fundamental for the evaluation of health care and 
patient satisfaction after surgery [2]. 
Regarding outcomes, what concerned more the health professionals were the 
mortality and complication rates. Since these parameters have improved, as a result of 
surgical techniques enhancement, patient’s quality of life (QOL) is now more than ever 
a central aspect [3-5]. Although satisfaction cannot be considered as an objective 
indicator of the quality of anesthesia care, it remains the best way to assess the 
outcome from the point of view of the patient [6]. Patient satisfaction was illustrated 
as the most clinically relevant measure of outcome [7] and also became a fundamental 
step in processes of hospital accreditation [8]. Therefore it’s vital to estimate patients’ 
quality of recovery (QoR) from their perspective, what might be said to be connected 
with the perception of their own QOL. 
Quality of life is defined by the World Health Organization as the individual perception 
of one’s position in life, in the context of his culture, objectives, expectations and 
worries [9]. The complexity and subjectivity of this concept makes it difficult to 
evaluate and even more difficult to measure appropriately [10]. So the question arises: 
how can we define and assess changes in the QOL after surgery?  
A valid and reliable measure of quality of recovery after anesthesia and surgery, the 
QoR-40 was developed by Myles et al. [11]. It is a 40-item questionnaire with five main 
dimensions: emotional state, physical comfort, physiological support, physical 
independence and pain. It showed especially superior content validity and construct 
validity, when compared to other pre-existing questionnaires, and did not reveal any 
negative ratings [1]. This questionnaire was speciﬁcally designed to measure a 
patient’s health status after surgery and anesthesia and has been proposed as a 
measure of outcome in clinical trials [11]. It has been demonstrated a significant 
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correlation of the Qor-40 sores with the SF-36 questionnaire (an extensive validated 
measure of quality of life and with clinical utility in a broad range of clinical settings) 
[12-14] [20]. A poor score on Qor-40 is associated with a poor score on the SF-36. This 
supports the belief that a poor quality of recovery (PQR) can predict a poor quality of 
life after surgery. [12] Hence, Qor-40 might be used as a predictive index to identify 
patients whose health status is about to change.  
If it was possible to foresee a PQR, a more effective support strategies could be 
proposed for these patients during their hospital stay  [12]. Furthermore, a poor 
quality of recovery was associated with a prolonged duration of stay in the hospital, 
readmission and post-operative complications indicating not only patient discomfort 
but also consumption of economic resources. [14] 
The aim of our study was to evaluate the incidence of Poor Quality of Recovery (PQR) 
in the PACU (Post Anesthesia Care Unit) and to compare their QoR scores before 
surgery, 24 hours after surgery and 3 months later. 
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Methods 
The study was conducted in the in the Post Anesthesia Care Unit (PACU), of Centro 
Hospitalar São João (CHSJ), Porto, Portugal. Ethical approval (Ethical n. º 127/2012) 
was provided by the Ethical committee of CHSJ (Comissão de Ética para a Saúde do 
Hospital de São João – Chairperson Prof Filipe N.A.S. Almeida). Written informed 
consent was obtained from all patients. 
Centro Hospitalar de São João is an 1124-bed tertiary hospital in a major metropolitan 
area that serves 3,000,000 people. This prospective study was conducted in the 12-bed 
PACU over a 4-week period from Monday through Thursday (from 18 June to 12 July 
2012). 
Every patient admitted to the PACU, during this period of time, who was able to 
provide written informed consent was included in the study. Exclusion criteria were 
patient refusal, incapacity of providing informed consent, a score of <25 in the mini-
mental state examination test (MMSE), age under 18 years, foreign nationality, known 
neuromuscular disease, urgent/emergent surgery and cardiac surgery, neurosurgery or 
other procedures that required therapeutic hypothermia. 
A total of 221 patients were enrolled in the study. Baseline demographic data were 
collected for descriptive purposes.   
All patients were interviewed in the eve. It was then conducted a small consultation to 
obtain consent to perform MMSE test and to collect the medical history.  
The validated QoR-40 Portuguese version was used to measure health status before 
surgery (T0), 24h after surgery (T1) and 3 months after surgery (T2). QoR-40 is a 40-
item questionnaire, developed for the purpose of measuring quality of recovery 
following anesthesia and surgery. It contains five sub-scales: physical comfort, 
emotional state, patient support, physical independence, and pain. Each item is rated 
on a scale of 1 to 5, providing a minimum score of 40 and maximum of 200. It was 
developed to measure early postoperative health status [12]. 
The questionnaire was completed with direct assistance from one of the investigators. 
The investigator asked the patient to rate each of the items on the QoR-40 by reading 
each item, asking the patient to provide a rating and then proceeding on to the next 
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item until all 40 items had been addressed. Completed questionnaire data were coded 
and entered into a database. After discharged from the hospital patients were 
contacted by telephone for the 3 months follow up and repeated de Qor-40 using the 
same method. 
Poor quality of recovery (PQR) was defined for patients with a QoR-40 score lower to 
the mean QoR score at T1 minus 1 standard deviation.  
The anesthesiologist in charge was blinded to patient involvement in the study.  
Conduct of anesthesia, including the choice of type of anesthesia or whether to use or 
not a muscle relaxant (and what type) was at the discretion of the anesthesiologist. 
Anesthesia was provided and monitored according to the criteria of the 
anesthesiologist in charge, but this conduct followed minimum departmental 
standards. Neuromuscular blocking drugs (NMBD) were used for tracheal intubation, 
and additional boluses were provided, if needed. No written policy exists concerning 
the use of neuromuscular monitoring so this was performed at the discretion of the 
anesthesiologist. To ensure that the anesthesiologist remained blinded to the patients’ 
participation in the study, we did not attempt to observe the use or interpretation of 
TOF (Train Of Four) intraoperatively. The anesthesiologist was free to decide whether 
to reverse the neuromuscular blockade (NMB) with neostigmine at the conclusion of 
the surgical procedure.  
Usually, the patient was extubated in the operating room and transferred to the PACU. 
Criteria for extubation included sustained head lift or hand grip for more than 5 
seconds, the ability to follow simple commands, a stable ventilatory pattern with an 
acceptable arterial oxygen saturation (SpO2) > 95%, and a TOF ratio of greater than 
0.80. All subjects were administered 100% oxygen by a facemask after tracheal 
extubation. The anesthesiologist was free to decide whether to administer oxygen 
during the time between transfer to the cart and admission to the PACU. 
Upon arrival to the PACU oxygen was provided to all subjects by either a nasal cannula 
or facemask. 
Temperature and Visual Analogic Scale (VAS) for pain were evaluated at PACU 
admission. 
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A standardized data collection sheet was completed for each patient.  
The recorded patients characteristics were: age, gender, weight, height, BMI, 
benzodiazepines administration before surgery, chronic benzodiazepines use, site of 
surgery (intra-abdominal, musculoskeletal, head and neck), American Society of 
Anesthesiologists physical status (ASA-PS), Revised Cardiac Risk Index (RCRI), duration 
of preoperative fluid fasting, type of anesthesia, duration of surgery, length of stay 
(LOS) in the PACU. 
The magnitude of the surgical procedure was classified as major (surgery in which body 
cavities or major vessels are exposed to ambient temperature such as major 
abdominal, thoracic, or major vascular, thoracic spine surgery with instrumentation, or 
hip arthroplasty), medium (surgery in which body cavities are exposed to a lesser 
degree such as appendectomy), and minor surgery (superficial surgery).  Major surgery 
was defined as a surgery requiring a hospital stay of 2 or more days. 
Clinical risk factors (history of chronic obstructive lung disease, history of ischemic 
heart disease, history of compensated or prior heart failure, history of cerebrovascular 
disease, diabetes mellitus and renal insufficiency) and surgical risk (high-risk defined as 
intrathoracic, intraperitoneal, or suprainguinal vascular surgery, or surgery involving 
large blood loss or fluid shifts) were defined according to the Cardiac Risk Stratification 
for Noncardiac Surgical Procedures of the 2007 guidelines on Perioperative 
Cardiovascular Evaluation and Care for Noncardiac Surgery of the American College of 
Cardiology/American Heart Association Task Force on Practice Guidelines [15]. 
Data for other preoperative clinical information regarding chronic obstructive 
pulmonary disease (COPD), hypertension and dyslipidemia were collected from routine 
clinical documentation entered into the institution’s perioperative clinical information 
system. 
Residual neuromuscular block (RNMB) was defined as TOF<0.9 and it was quantified at 
admission to the PACU using acceleromyography of the adductor pollicis muscle (TOF-
Watch®). [16, 17] 
For delirium screening, at PACU discharge and in the ward the next day after surgery, 
the nursing delirium screening scale were (Nu-DESC) [18] used, and patients with a Nu-
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DESC score of 2 or more points at least at one evaluation were considered delirium 
positive. Patients were tested for delirium by the research team at the time they were 
formally declared to be ‘ready for discharge’ to the regular ward by the physician in 
charge of the recovery room. In addition, the patients were seen on the morning of the 
first postoperative day. 
Patients were asked to provide a global rating of their nausea intensity using a 100 mm 
Nausea VAS. Postoperative nausea and vomiting (PONV) was evaluated and measured 
with PONV Intensity scale described by Myles et al. [19]. 
At discharge of PACU VAS for pain was measured. 
 
 
Statistical Analysis   
 
Descriptive analysis of variables was used to summarize data. Ordinal and continuous 
data found not to follow a normal distribution, based on the Kolmogorov–Smirnov test 
for normality of the underlying population, are presented as median and interquartile 
range. Non parametric tests were used to compare continuous variables and Chi-
square or Fisher’s exact test to compare proportions between 2 groups of subjects.  
The related samples Wilcoxon signed rank test was used to compare Qor-40 scores. 
Differences were considered statistically significant when p was <0.05. 
Data was analyzed using SPSS software for Windows Version 19.0 (SPSS Inc., Chicago, 
IL, USA). 
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Results 
Form 221 patients consecutively admitted in the PACU during the study period, a total 
of 114 were studied.  
One-hundred and seven patients were excluded from this initial cohort: 66 were lost to 
the follow-up or had missing information crucial to data analysis, 12 patients were 
admitted to a surgical intensive care unit, 8 patients were unable to provide informed 
consent or had a MMSE <25, 2 patients did not undergo surgery, 2 patient underwent 
neurosurgery, 11 patient were less than 18 years old, 3 patient did not speak 
Portuguese and 3 patients refused to participate.  
Table 1 lists pre-admission patient’s characteristics and outcomes.  
PQR patients had more frequently PONV (42% versus 25%, p= 0.038). 
At T1, mean QoR-40 score was 169 and PQR patients were identified if their QoR-40 
score was lesser than 142. PQR occurred in 26 patients (24%).  
Table 2 shows global median scores comparing PQR with patients with no PQR at T0, 
T1 and T2. 
According to the various QoR-40 sub-scales, PQR patients showed lower median scores 
at T0 for emotional state (24 vs. 39, p<0,001), physical comfort (29 vs. 55, p<0,001) and 
pain (10 vs. 33, p<0,001), while in the other sub-scales (psychological support and 
physical independence) the results were similar. 
At T1 patients showed lower median scores for emotional state (23 vs. 40, p<0.001), 
physical comfort (30 vs. 53, p<0.001), pain (13 vs. 31, p<0,001), psychological support 
and for physical independence (14 vs. 22, p=0,001). 
 At T2 patients presented lower median scored for emotional state (22 vs. 41, 
p<0,001), physical comfort (28 vs. 58, p<0,001) and pain (10 vs. 34, p<0.001), while in 
the other sub-scales (psychological support and physical independence) the results 
were analogous. 
Table 3 shows that there were no differences observed in global scores and scores for 
each QoR-40 dimensions for patients with PQR comparing scores observed before 
surgery and 3 months after surgery.  
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Table 4 shows global scores and scores for each QoR-40 dimensions for patients 
without PQR comparing scores observed before surgery and 3 months after surgery. In 
physical comfort dimension there was an improvement in median scores but for global 
score and for the other dimensions there were no differences observed. 
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Discussion 
The principal findings of this study were as follow: the incidence of PQR was 24%; 
patients with PQR have lower QoR scores prior to surgery and 3 months after surgery. 
The incidence of PQR 24 hours after surgery in our study (24%) is in accordance with 
the current literature [13], although there is a lack of studies with the same 
methodology after non cardiac surgery [12] [20]. 
PQR patients had PONV more frequently than what was expected because PONV are 
included in QoR individual questions and are well weighted in the questionnaire. This 
was already studied by Myles et al [19] that concluded that patients with PONV had 
lower scores of QoR. 
PQR patients may be identified prior to surgery, because these patients have lower 
median scores (p < 0,001) for the global QoR score, and for some of the QoR 
dimensions (Pain, Physical Comfort and Emotional State dimension) measured at T0. 
This may be important because as soon as these patients are identified the sooner 
efforts might be taken to provide important measures capable of improving quality of 
recovery. Important measures trying to improve scores in Pain, Physical Comfort and 
Emotional State dimensions could be implemented in patients previously identified in 
order to improve QoR-40 scores 24 hours after surgery, and thereby improving quality 
of recovery.  
As others had proposed in analogous studies [12] PQR 24h after anesthesia can predict 
a poor quality of life at 3 months. QoR-40 and Quality of Recovery are related with 
quality of life 3 months after surgery [12], that is why we suggest that improving the 
Qor-40 score after surgery might be able to improve the quality of life. Others have 
described the relationship between quality of recovery after surgery and quality of life 
up to 3 years [13] so QoR may be considered an indirect tool to measure QOL.  
The results of our study showing a decrease at T2 in QoR global score and at several 
dimensions (Pain, Physical Comfort and Emotional State) suggests that patients with 
PQR maintain lower quality of recovery until at least 3 months after surgery, especially 
in Pain and Emotional State dimensions.  
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In our study the Psychological support and Physical Independence dimensions at T0 
and T2 showed to be equal in both Patients with PQR and without PQR, which suggests 
that these dimensions may not contribute to predict those patients who will develop 
PQR and may not contribute for the low quality of recovery after 3 months of surgery.  
In patients with PQR and comparing scores before and after surgery there were no 
observed differences but in patients without PQR physical comfort score improved 3 
months after surgery.  It was expected a more global improvement in QoR after 
surgery but these results might suggest that after surgery in patients without PQR the 
more accurate dimension to measure improvement might have been physical comfort 
because before surgery these patients might have no derangements in other 
dimensions. In contrary patients with PQR were already affected in all dimensions and 
were not able to improve. 
In order to reduce bias we were strict about timing measurements since it was 
essential in a dynamic process such as postoperative recovery. Also by selecting a 
heterogeneous surgical population we ought to be able to measure great extremes of 
comfort and mobility [12]. In this study it was the investigator that administered the 
questionnaire, what may be seen as a more efficient use of resources, as complete and 
a timely data were collected [21]. 
 
Limitations of the study 
 
A major limitation of our study was the high rate of losses to the follow-up leading to a 
rate of 52% of global answers.   
We did not use a previously validated tool to measure quality of life, assuming a 
relationship between quality of recovery and quality of life. But then again, QoR-40 
and SF-36 contain similar scopes and dimensions that will assist their association and 
also because they represent similar psychosocial aspects, they ought to be correlated 
[11-12]. 
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To conclude, Quality of Recovery is crucial for Quality of Life after surgery. QoR-40 
score is an important tool to assess Quality of Recovery and our study suggest that 
QoR-40 may be used prior to surgery to identify patients who will develop PQR. 
Moreover, recognizing the most affected dimensions could help to implement actions 
in order to achieve a better quality of recovery. However more studies are needed in 
order to validate this tool prior to surgery [12].  
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Table 1. Pre-admission patient characteristics and outcomes. 
 All 
(n=114) 
No PQR 
(n=88) 76% 
PQR 
(n=26) 24% 
 
P 
Age in years, median (IQR) 60 (43-68) 60 (42-68)  55 (44-71) 0.685
 a
 
Age group, n (%)    0.603
b
 
< 65 years 75 (66) 59 (67) 16 (62)  
 65 years 39 (34)   29 (33) 10 (38)  
Gender, n (%)    0.937
 b
 
Male 49 (43) 38 (43) 11 (42)  
Female 65 (57) 50 (57) 15 (58)  
ASA physical status, n (%)    0.543
 c
 
 I/II 87 (76) 66 (75) 21 (81)  
III/IV 27 (24)   22 (25) 5 (19)  
Body Mass Index in Kg/m
2
, median (IQR) 26 (24-30) 26 (24-30) 29 (24-32) 0.207
a
 
Duration of anaesthesia (min.), median (IQR) 120 (90-180) 120 (90-180) 120 (84-189) 0.868
a
 
Type of anesthesia, n (%)    0.062
a
 
General / Combined general locorregional 94 (82) 75 (85) 19 (73)  
Locorregional 20 (18) 13 (15) 7 (17)  
Site of surgery    0.860
c
 
Abdominal 52 (46) 39 (44) 13 (50)  
Musculoskeletal 49 (43) 39 (44) 10 (39)  
Head and neck 13 (11) 10 (11) 3 (11)  
Temperature at PACU admission, median (IQR) 35.5 (34.9–36.0) 35.5 (34.9-35.9) 35.7 (35.2 - 36.0) 0.201
 a
 
Hypertension, n (%) 56 (49) 46 (52) 10 (39) 0.216
 b
 
Hyperlipidemia, n (%) 40 (35) 32 (36) 8 (31) 0.599
b
 
COPD, n (%) 8 (7) 5 (6) 3 (12) 0.263
c
 
High-risk surgery, n (%) 28 (25) 22 (25) 6 (23) 0.841
b
 
Ischaemic heart disease, n (%) 7 (6) 5 (6) 2 (7) 0.503
c
 
Congestive heart disease, n (%) 3 (3) 2 (2) 1 (4) 0.544
c
 
Cerebrovascular disease, n (%) 1 (3) 1 (1) 0 0.772
c
 
Renal insufficiency, n (%) 9 (8) 8 (9) 1 (4) 0.346
 c
 
Insulin therapy for diabetes, n (%) 17 (15) 16 (18) 1 (4) 0.059
 c
 
Total RCRI, n (%)    0.676 
c
 
≤2 109 (96) 83 (95) 26 (96)  
>2 5 (4) 4 (5) 1 (4)  
Medication with benzodiazepines 31 (27) 22 (25) 9 (35) 0.333
b
 
Benzodiazepines premedication 43 (38) 31 (35) 12 (36) 0.536
b
 
Crystalloids, median (IQR) 1000 (1000-2000) 1000 (1000-2000) 1000 (1000-2600) 0.089
 a
 
Colloids, n (%) 3 (3) 2 (2) 1 (4) 0.579
 c
 
Erythrocytes, n (%) 2 (2) 2 (2) 0 0.569
 c
 
RNMB 19 (17) 16 (18) 3 (12) 0.715
c
 
PONV 34 (30) 22 (25) 12 (42) 0.038
b
 
Delirium 18 (16) 13 (15) 5 (19) 0.584
c
 
VAS for pain at PACU admission 0 (0-5) 0 (0-5) 0 (0-4) 0.378
a
 
VAS for pain at PACU discharge 0 (0-2) 0 (0-2) 1 (0-3) 0.599
a
 
SICU length of stay (minutes), median (IQR) 114 (85-146) 110 (81-144) 120 (110-188) 0.169 
a
 
a Mann-Whitney U test,  b Pearson χ2 , c Fisher´s exact test,  IQR, interquartile range 
ASA, American Society of Anesthesiologists; COPD, Chronic Obstructive Pulmonary Disease; RCRI, Revised Cardiac Risk Index; PACU, Post Anesthesia 
Care Unit; PONV, Postoperative Nausea and Vomiting; RNMB, Residual Neuromuscular blockade; VAS, Visual Analogic Scale 
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Table 2. Pre-admission patient QoR-40 scores and outcomes. 
 All 
(n=114) 
No PQR 
(n=88) 76% 
PQR 
(n=26) 24% 
 
P 
Emotional State T0 36 (27-42) 39 (33-42) 24 (22-28) <0.001 
Emotional State T1 38 (30 – 42) 40 (35-43) 23 (20-28) <0.001 
Emotional State T2 38 (29 – 44) 41 (33-45) 22 (21-37) <0.001 
Physical Comfort T0 54 (48 – 57) 55 (51-58) 29 (28-38) <0.001 
Physical Comfort T1 51 (43 -55) 53 (50- 56) 30 (25-41) <0.001 
Physical Comfort T2 57 (47 – 60) 58 (53 – 60) 28 (28-53) <0.001 
Physchological support T0 35 (34 – 35) 35 (34-35) 35 (35-35) 0.115 
Physchological support T1 35 (34 – 35) 35 (34 – 35) 35 (31 – 35) 0.166 
Physchological support T2 35 (34 – 35) 35 (34 – 35) 35 (34 – 35) 0.794 
Physical Independence T0 25 (23 – 25) 25 (23 – 25) 25 (23 – 25) 0.937 
Physical Independence T1 21 (15- 25) 22 (17 – 25) 14 (12 – 22) 0.001 
Physical Independence T2 25(24-25) 25 (24 -25) 25( 24- 25) 0.755 
Pain T0 31 (26 – 35) 33 (29-35) 10 (7 – 26) <0.001 
Pain T1 30 (25 – 32) 31 (28 – 33) 13 (10 – 24) <0.001 
Pain T2 32 (26 – 34) 34 (29 – 35) 10 (7 – 30) <0.001 
Global T0 180 ( 157- 190) 184 ( 170 – 192) 121 (117 – 139) <0.001 
Global T1 174 (151 – 183) 177 (166-187) 120 (107 – 134) <0.001 
Global T2 182 (161 – 196) 189 (173 -198) 119 (115 – 175) <0.001 
T0, before surgery; T1, 24 after surgery; T2, 3 months after surgery; PQR, Poor Quality of Recovery.  
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Table 3. QoR global score and scores for each QoR-40 dimensions in patients with PQR   
  Before surgery 3 months after surgery p 
Global  121 (117 – 139) 119 (115 – 175) 0.306 
Emotional State   24 (22-28) 22 (21-37) 0.935 
Physical Comfort   29 (28-38) 28 (28-53) 0.108 
Psychological support   35 (35-35) 35 (34 – 35) 0.309 
Physical Independence   25 (23 – 25) 25( 24- 25) 0.502 
Pain  10 (7 – 26) 10 (7 – 30) 0.311 
QoR-40, quality of recovery score; PQR, poor quality of recovery 
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Table 4. QoR global score and scores for each QoR-40 dimensions in patients without PQR   
  Before surgery 3 months after surgery p 
Global  184 ( 170 – 192) 189 (173 -198) 0.306 
Emotional State   39 (33-42) 41 (33-45) 0.110 
Physical Comfort   55 (51-58) 58 (53 – 60) 0.004 
Psychological support   35 (34-35) 35 (34-35) 0.905 
Physical Independence   25 (23 – 25) 25 (24 -25) 0.747 
Pain  33 (29-35) 34 (29 – 35) 0.886 
QoR-40, quality of recovery score; PQR, poor quality of recovery 
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Photomicrographs must have internal scale markers. If photographs of people are used,
their identities must be obscured or the picture must be accompanied by written consent
to use the photograph.
If a figure has been published before, the original source must be acknowledged and
written permission from the copyright holder for both print and electronic formats should
be submitted with the material. Permission is required regardless of authorship or
publisher, except for documents in the public domain.
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Captions should be typed in 1.5 spacing, beginning on a separate page. Each figure should
be assigned an Arabic numeral, e.g. (Figure 3) and a brief title as a heading. Internal scales
should be explained and staining methods for photomicrographs should be identified.
Units of measurement
Scientific measurements should be given in SI units. Blood pressure, however, may be
expressed in mmHg and haemoglobin as g dL-1.
Abbreviations and symbols
Authors are discouraged from using abbreviations. If an abbreviation is necessary please
use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term
for which an abbreviation stands should precede its first use in the text unless it is a
standard unit of measurement.
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production staff will create a URL with the SDC file. The URL will be placed in the call-out
within the article. SDC files are not copy-edited by LWW staff, they will be presented
digitally as submitted. For a list of all available file types and detailed instructions, please
visit http://links.lww.com/A142.
SDC Call-outs
Supplemental Digital Content must be cited consecutively in the text of the submitted
manuscript. Citations should include the type of material submitted (Audio, Figure, Table,
etc.), be clearly labeled as "Supplemental Digital Content," include the sequential list
number, and provide a description of the supplemental content. All descriptive text should
be included in the call-out as it will not appear elsewhere in the article. 
For example: 
We performed many tests on the degrees of flexibility in the elbow (see Video,
Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results
inconclusive.
List of Supplemental Digital Content
A listing of Supplemental Digital Content must be submitted at the end of the manuscript
file. Include the SDC number and file type of the Supplemental Digital Content. This text will
be removed by our production staff and not be published.
For example:
Supplemental Digital Content 1.wmv
SDC File Requirements
All acceptable file types are permissible up to 10 MBs. For audio or video files greater than
10 MBs, authors should first query the journal office for approval. For a list of all available
file types and detailed instructions, please visit http://links.lww.com/A142.
Reprints
Reprints may be purchased using the appropriate form that will be made available with
proofs. Orders should be sent when the proofs are returned; orders received after this time
cannot be fulfilled.
Article Types
Randomised Controlled Trials 
Authors are requested to report these in accordance with the CONSORT (Consolidated
Standards of Reporting Trials) statement [www.consort-statement.org]. This ensures that
enough information is provided for editors, peer reviewers, and readers to see how the
study was performed and to judge whether the findings are likely to be reliable (see EJA
Editorial: Adherence to guidelines for improved quality of data reporting: where are we
today?). Please provide the following:
• A flow chart showing the progress of participants through the study 
• A checklist for editors and reviewers (not for publication) showing that you have
described the recommended respective key points in your report.
Maximum length of reports of randomised controlled trials is 3500 words. Please provide a
structured abstract (max. 250 words).
Observational Study (Cohort, Case-control, Cross-sectional, Case Series)
Authors are requested to report these in accordance with the STROBE (STrengthening the
Reporting of OBservational studies in Epidemiology) statement [www.strobe-
statement.org].
Studies of Diagnostic Accuracy
Authors are requested to report these in accordance with STARD (STandard for the
Reporting of Diagnostic accuracy) statement [www.stard-statement.org].
Systematic Reviews (with or without meta-analysis)
Authors are requested to submit these as ‘Original articles’ (not ‘Reviews’) and report them
in accordance with the PRISMA (Transparent Reporting of Systematic Reviews and Meta-
Analyses) Statement [www.prisma-statement.org]. This ensures that enough information is
provided for editors, peer reviewers, and readers to see how the study was performed and
to judge whether the findings are likely to be reliable (see EJA Editorial: Adherence to
guidelines for improved quality of data reporting: where are we today?). Please provide the
following:
• A flow chart showing the progress of retrieved reports through the review
• A checklist for editors and reviewers (not for publication) showing that you have
described the recommended respective key points in your report.
Maximum length of reports of systematic reviews is 3500 words. Please provide a
structured abstract (max. 250 words). Authors are encouraged to publish additional
material (for instance, large tables, figures with forest plots, data from subgroup analyses
etc.) as Supplemental Digital Content (see above for details).
Conventional, Non-systematic Reviews
These are usually commissioned. Maximum length of reviews is 3500 words. Please provide
an unstructured abstract (max. 250 words). Please include a title page giving the author's
name, address, email address, phone and fax numbers, as well as an Acknowledgement
statement (see paragraph: Acknowledgements) and signed copyright forms.
Practice Guidelines
In general, published statements intended to guide clinical care (e.g., Guidelines, Practice
Parameters, Recommendations, Consensus Statements, Position Papers) should describe:
1. The clinical problem to be addressed;
2. The mechanism by which the statement was generated;
3. A review of the evidence for the statement (if available), and;
4. The statement on practice itself.
As more than one group or society may issue statements on the same topic, this often
results in confusion amongst clinicians. To minimize confusion and to enhance transparency,
such statements should begin with the following bulleted phrases, followed by brief
comments addressing each phrase:
What other guideline statements are available on this topic?
Why was this guideline developed?
How does this statement differ from existing guidelines?
Why does this statement differ from existing guidelines?
02/10/12Editorial Manager - European Journal of Anaesthesiology
9/10edmgr.ovid.com/eja/accounts/ifauth.htm
Editorials
Editorials discuss issues that are not directly related to published material. Editorials are
usually commissioned. Editorials should be up to 1500 words long with no more than 15
references. Please include a title page giving all authors' names, addresses, email
addresses, phone and fax numbers, as well as an Acknowledgement statement (see
paragraph: Acknowledgements) and signed copyright forms. Editorials do not have an
abstract.
Commentaries
Commentaries discuss issues that are directly related to published material. Commentaries
accompany original articles, critically appraise their results and put their conclusions into a
wider context. Commentaries are always commissioned and should be up to 1000 words
long with no more than 10 references. Commentaries do not have an abstract. Please
include a title page giving the author's name, address, email address, phone and fax
numbers, as well as an Acknowledgement statement (see paragraph: Acknowledgements)
and signed copyright forms.
Correspondence
In this section, we publish case reports, letters and replies. Items in the Correspondence
section are peer reviewed. Please look at a very recent copy of the European Journal of
Anaesthesiology to see how the material should be presented. The format (layout) for the
Correspondence section is quite different from our other articles. The absolute maximum is
1000 words, which must include the space for any tables and illustrations (this is
approximately two sides of printed matter in the Journal). References are limited to seven.
For case reports please send copies of patient consent forms which clearly grant permission
for the publication of photographs or other material that might identify the patient. A
statement to the effect that such consent had been obtained must be included in your
paper. 
The standard covering letter should be submitted with the correspondence.
Correspondence articles do not have an abstract. Please include a title page giving the
author's name, address, email address, phone and fax numbers, as well as an
Acknowledgement statement (see paragraph: Acknowledgements) and signed copyright
forms.
English language editing 
If you are inexperienced in publishing medical articles in English then it may be helpful to
have your manuscript reviewed by a professional editor so that you submit it in
grammatically and syntactically acceptable English. The list below is provided for the benefit
of authors seeking assistance in writing and editing their manuscripts. The EJA does not
endorse any writing/editing services.
American Journal Experts (http://www.journalexperts.com/?rcode=LWW1 Discount
Available for LWW Journal Authors) 
BioMedES (Biomedical Editorial Services) (http://www.biomedes.co.uk) 
Biomedical Science Writers, LLC (http://www.biomedicalsciencewriters.com/index.htm) 
BoldFace Editors (http://www.boldfaceeditors.com) 
Cambridge Language Consultants (http://www.camlang.com/proof.cfm) 
Council of Science Editors Manuscript Services Listing
(http://www.councilscienceeditors.org) 
Editage (http://www.editage.com) 
Elizabeth Betsch, ELS , Medical Edits.com (ejb@medicaledits.com) 
English Science Editing (http://www.english-science.com/journals.html) 
English Manager Science Editing (Australia) (http://www.sciencemanager.com/) 
ScienceDocs (http://www.sciencedocs.com) 
SciTechEdit International Science Editing (http://www.internationalscienceediting.com/) 
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